Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples